EnVVeno Medical Corporation
NVNO
Clasificación en acciones
#40245
enVVeno Medical Corporation, based in Irvine, California, is a medical device... enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency. This device requires an open surgical procedure for implantation, which involves making a 5-to-6-inch incision in the patient's upper thigh to facilitate placement into the femoral vein. In addition to the VenoValve, enVVeno Medical is actively developing the enVVe system. This innovative system represents a non-surgical, transcatheter approach to venous valve replacement, comprising the enVVe valve itself, a dedicated delivery mechanism, and various supplementary accessories. The company previously operated under the name Hancock Jaffe Laboratories, Inc., before officially rebranding to enVVeno Medical Corporation in October 2021.
Precio por acción
$10.71
Última sincronización: 2026-07-31
Capitalización bursátil
$176.75K
Cambio (1 día)
0.79%
Cambio (1 año)
169,900.00%
País
US
Comercio EnVVeno Medical Corporation (NVNO)
Categoría
Healthcare
Capitalización de mercado de EnVVeno Medical Corporation(NVNO)
Capitalización bursátil: $176.75K
A fecha de October 2026, EnVVeno Medical Corporation tiene una capitalización de mercado de $176.75K. Esto convierte a EnVVeno Medical Corporation en la 40245th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de EnVVeno Medical Corporation desde 2018 hasta 2026
NVNO en comparación con los más populares 5 títulos stocks
| Precio por NVNO | Activo B | Capital del mercado en B | Resultados | |
|---|---|---|---|---|
$393,979,413
$82.63
|
$5.167T | +6,253,641,474,281.09% | ||
|
$382,369,742
$82.63
|
$5.015T | +6,069,360,977,213.03% | ||
|
$313,259,796
$82.63
|
$4.108T | +4,972,377,717,332.48% | ||
|
$297,514,583
$82.63
|
$3.902T | +4,722,453,701,283.97% | ||
|
$205,067,178
$82.63
|
$2.689T | +3,255,034,574,390.62% |
